Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.2 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 40.66.
Market Cap
8.2T
Revenue
4.59T
Profits
201.81B
PE Ratio
40.66
Profit Margin
4.40%
Dividend Yield
0.43%
1063 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 869.41B | -1.22% | 3,491,962 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 535.63B | -0.94% | 7,266,666 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 358.55B | -1.13% | 6,680,630 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 335.78B | 0.67% | 5,232,602 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 281.10B | -1.30% | 2,749,493 | 60.44B |
| 6 | NVS | Novartis AG | 277.90B | -2.00% | 1,005,051 | 56.58B |
| 7 | MRK | Merck & Co., Inc. | 277.36B | -1.11% | 7,326,726 | 65.77B |
| 8 | NVO | Novo Nordisk A/S | 206.23B | 0.09% | 15,699,815 | 50.57B |
| 9 | AMGN | Amgen Inc. | 177.61B | -0.61% | 3,296,462 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 176.32B | 0.32% | 2,533,631 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 166.40B | -1.64% | 8,898,210 | 29.44B |
| 12 | ISRG | Intuitive Surgical, Inc. | 160.61B | 0.39% | 1,563,031 | 10.58B |
| 13 | ABT | Abbott Laboratories | 151.56B | 0.82% | 6,310,831 | 45.13B |
| 14 | PFE | Pfizer Inc. | 150.92B | -0.19% | 48,291,782 | 63.32B |
| 15 | DHR | Danaher Corporation | 124.33B | 0.42% | 4,481,860 | 24.78B |
| 16 | BMY | Bristol-Myers Squibb Company | 114.87B | -0.60% | 10,411,985 | 48.48B |
| 17 | SYK | Stryker Corporation | 112.69B | 0.65% | 2,648,729 | 25.27B |
| 18 | CVS | CVS Health Corporation | 111.47B | 0.58% | 9,387,808 | 405.62B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 107.87B | -0.62% | 1,112,498 | 12.22B |
| 20 | SNY | Sanofi | 104.17B | -1.35% | 1,774,541 | 54.60B |
| 21 | GSK | GSK plc | 100.99B | -0.06% | 2,016,174 | 43.29B |
| 22 | MDT | Medtronic plc | 100.09B | 0.46% | 7,352,326 | 35.48B |
| 23 | HCA | HCA Healthcare, Inc. | 95.17B | -0.10% | 774,340 | 76.39B |
| 24 | MCK | McKesson Corporation | 92.45B | 1.49% | 2,020,177 | 403.43B |
| 25 | BSX | Boston Scientific Corporation | 84.08B | 1.02% | 25,532,844 | 20.61B |
| 26 | ELV | Elevance Health, Inc. | 80.98B | -0.48% | 1,410,399 | 200.42B |
| 27 | CI | The Cigna Group | 75.14B | 0.73% | 1,201,190 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 72.14B | -1.66% | 774,510 | 14.92B |
| 29 | MDLN | Medline Inc. | 54.99B | -0.36% | 13,108,030 | 29.14B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 53.62B | -0.48% | 5,131,369 | 28.48B |
| 31 | COR | Cencora, Inc. | 49.74B | 1.16% | 3,700,875 | 328.68B |
| 32 | ARGX | argenx SE | 49.13B | -2.51% | 580,465 | 4.74B |
| 33 | EW | Edwards Lifesciences Corporation | 47.65B | -0.53% | 3,332,528 | 6.30B |
| 34 | IDXX | IDEXX Laboratories, Inc. | 45.14B | -1.21% | 758,857 | 4.45B |
| 35 | BDX | Becton, Dickinson and Company | 43.64B | 5.87% | 6,374,005 | 22.23B |
| 36 | CAH | Cardinal Health, Inc. | 43.39B | -3.24% | 1,868,391 | 250.74B |
| 37 | TEVA | Teva Pharmaceutical Industries Limited | 41.93B | -0.91% | 10,801,786 | 17.35B |
| 38 | HLN | Haleon plc | 40.51B | 0.76% | 24,338,136 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.51B | -2.34% | 1,143,976 | 4.29B |
| 40 | ZTS | Zoetis Inc. | 36.72B | -21.50% | 13,803,272 | 9.53B |
| 41 | ONC | BeOne Medicines AG | 35.24B | 1.17% | 441,187 | 5.74B |
| 42 | WAT | Waters Corporation | 34.41B | 0.27% | 2,014,614 | 3.77B |
| 43 | A | Agilent Technologies, Inc. | 33.53B | 0.82% | 2,281,353 | 7.07B |
| 44 | ALC | Alcon Inc. | 31.55B | -2.34% | 4,383,327 | 10.63B |
| 45 | NTRA | Natera, Inc. | 31.39B | 2.20% | 2,765,492 | 2.31B |
| 46 | RVMD | Revolution Medicines, Inc. | 30.30B | -5.67% | 3,174,737 | - |
| 47 | RMD | ResMed Inc. | 30.01B | -1.31% | 686,827 | 5.54B |
| 48 | IQV | IQVIA Holdings Inc. | 29.82B | 1.23% | 1,119,289 | 16.63B |
| 49 | RPRX | Royalty Pharma plc | 29.76B | -1.03% | 5,602,076 | 2.44B |
| 50 | HUM | Humana Inc. | 29.67B | 0.32% | 1,178,529 | 137.20B |
| 51 | BIIB | Biogen Inc. | 28.25B | 0.37% | 737,386 | 9.94B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 27.90B | -0.64% | 3,828,042 | 20.98B |
| 53 | VEEV | Veeva Systems Inc. | 27.48B | 0.54% | 4,101,503 | 3.20B |
| 54 | CNC | Centene Corporation | 27.15B | -0.63% | 4,444,738 | 178.33B |
| 55 | MTD | Mettler-Toledo International Inc. | 26.71B | -0.58% | 198,735 | 4.03B |
| 56 | PHG | Koninklijke Philips N.V. | 26.31B | -0.26% | 1,309,111 | 20.34B |
| 57 | UTHR | United Therapeutics Corporation | 24.16B | -4.62% | 830,872 | 3.17B |
| 58 | BNTX | BioNTech SE | 23.52B | -2.35% | 1,118,849 | 3.23B |
| 59 | DXCM | DexCom, Inc. | 23.50B | 0.91% | 5,080,281 | 4.82B |
| 60 | WST | West Pharmaceutical Services, Inc. | 22.75B | 3.03% | 1,610,524 | 3.22B |
| 61 | INSM | Insmed Incorporated | 22.66B | -23.41% | 13,713,239 | 819.56M |
| 62 | LH | Labcorp Holdings Inc. | 21.16B | 0.43% | 745,958 | 14.14B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.13B | 0.90% | 739,938 | 11.28B |
| 64 | ILMN | Illumina, Inc. | 20.99B | -2.71% | 1,240,902 | 4.39B |
| 65 | STE | STERIS plc | 20.96B | -0.35% | 557,781 | 5.83B |
| 66 | VTRS | Viatris Inc. | 20.25B | 9.03% | 34,752,121 | 14.56B |
| 67 | ROIV | Roivant Sciences Ltd. | 20.24B | -1.87% | 3,570,308 | 13.31M |
| 68 | INCY | Incyte Corporation | 19.53B | -2.08% | 1,021,626 | 5.36B |
| 69 | MRNA | Moderna, Inc. | 19.26B | -0.51% | 8,487,337 | 2.23B |
| 70 | GMAB | Genmab A/S | 17.00B | -2.98% | 3,498,101 | 3.90B |
| 71 | THC | Tenet Healthcare Corporation | 16.72B | -0.20% | 1,290,183 | 21.46B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 16.13B | 0.65% | 1,792,311 | 8.41B |
| 73 | RGC | Regencell Bioscience Holdings Limited | 15.56B | 14.06% | 368,810 | - |
| 74 | ASND | Ascendis Pharma A/S | 15.21B | 4.34% | 1,491,354 | 998.25M |
| 75 | NBIX | Neurocrine Biosciences, Inc. | 15.05B | 1.75% | 1,790,201 | 3.10B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 14.24B | -0.70% | 1,129,351 | 4.44B |
| 77 | SMMT | Summit Therapeutics Inc. | 13.31B | -3.92% | 2,720,985 | - |
| 78 | BBIO | BridgeBio Pharma, Inc. | 13.21B | -0.94% | 2,875,459 | 502.08M |
| 79 | SNN | Smith & Nephew plc | 12.95B | -0.69% | 647,677 | 6.16B |
| 80 | PEN | Penumbra, Inc. | 12.77B | 0.14% | 683,301 | 1.45B |
| 81 | DVA | DaVita Inc. | 12.60B | 1.23% | 1,817,574 | 13.84B |
| 82 | IONS | Ionis Pharmaceuticals, Inc. | 12.56B | -1.08% | 1,885,689 | 1.06B |
| 83 | SOLV | Solventum Corporation | 12.41B | 0.93% | 1,698,438 | 8.26B |
| 84 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.33B | -0.90% | 384,447 | 1.13B |
| 85 | MEDP | Medpace Holdings, Inc. | 12.24B | 0.45% | 346,675 | 2.68B |
| 86 | GH | Guardant Health, Inc. | 12.23B | 0.01% | 2,390,389 | 982.02M |
| 87 | ALGN | Align Technology, Inc. | 12.06B | -3.19% | 753,213 | 4.10B |
| 88 | ELAN | Elanco Animal Health Incorporated | 11.99B | -8.29% | 10,180,104 | 4.89B |
| 89 | COO | The Cooper Companies, Inc. | 11.92B | -0.02% | 2,096,241 | 4.15B |
| 90 | FMS | Fresenius Medical Care AG | 11.76B | 3.05% | 1,069,432 | 22.32B |
| 91 | EXEL | Exelixis, Inc. | 11.74B | -5.11% | 3,519,138 | 2.38B |
| 92 | RDY | Dr. Reddy's Laboratories Limited | 11.54B | -0.22% | 3,140,549 | 3.85B |
| 93 | GMED | Globus Medical, Inc. | 11.54B | -4.65% | 2,911,075 | 2.94B |
| 94 | AXSM | Axsome Therapeutics, Inc. | 11.33B | -1.08% | 919,075 | 708.24M |
| 95 | PODD | Insulet Corporation | 11.11B | 6.03% | 2,827,013 | 2.90B |
| 96 | RVTY | Revvity, Inc. | 11.05B | -0.24% | 2,004,960 | 2.90B |
| 97 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.92B | -1.50% | 2,337,970 | 1.09B |
| 98 | BTSG | BrightSpring Health Services, Inc. | 10.89B | 0.38% | 2,434,108 | 13.65B |
| 99 | EHC | Encompass Health Corporation | 10.63B | 2.04% | 1,329,086 | 6.07B |
| 100 | BMRN | BioMarin Pharmaceutical Inc. | 10.46B | -0.88% | 2,112,080 | 3.24B |
| 101 | UHS | Universal Health Services, Inc. | 10.41B | 1.23% | 1,254,646 | 17.76B |
| 102 | ENSG | The Ensign Group, Inc. | 10.10B | -0.93% | 634,296 | 5.27B |
| 103 | ABVX | ABIVAX Société Anonyme | 10.04B | -1.49% | 1,181,493 | 5.37M |
| 104 | MOH | Molina Healthcare, Inc. | 9.99B | -2.83% | 410,278 | 43.10B |
| 105 | ICLR | ICON Public Limited Company | 9.54B | 0.70% | 1,121,629 | 8.10B |
| 106 | MASI | Masimo Corporation | 9.35B | 0.01% | 1,241,492 | 1.56B |
| 107 | PRAX | Praxis Precision Medicines, Inc. | 9.28B | -1.42% | 457,694 | 7.46M |
| 108 | CYTK | Cytokinetics, Incorporated | 9.24B | -0.73% | 8,400,732 | 105.82M |
| 109 | BAX | Baxter International Inc. | 9.03B | 3.00% | 5,403,725 | 11.32B |
| 110 | CRL | Charles River Laboratories International, Inc. | 8.96B | -0.03% | 1,346,924 | 4.03B |
| 111 | TEM | Tempus AI, Inc. | 8.88B | -7.53% | 10,918,101 | 1.36B |
| 112 | KRYS | Krystal Biotech, Inc. | 8.75B | 2.67% | 602,249 | 417.30M |
| 113 | NUVL | Nuvalent, Inc. | 8.09B | -1.76% | 593,730 | - |
| 114 | HSIC | Henry Schein, Inc. | 8.03B | -2.68% | 2,391,165 | 13.38B |
| 115 | IBRX | ImmunityBio, Inc. | 8.01B | -7.40% | 10,809,517 | 140.98M |
| 116 | ATR | AptarGroup, Inc. | 7.98B | 2.02% | 456,554 | 3.87B |
| 117 | TECH | Bio-Techne Corporation | 7.97B | 7.39% | 5,147,216 | 1.21B |
| 118 | GKOS | Glaukos Corporation | 7.88B | -0.83% | 294,920 | 551.35M |
| 119 | HALO | Halozyme Therapeutics, Inc. | 7.72B | -1.75% | 1,517,207 | 1.40B |
| 120 | PCVX | Vaxcyte, Inc. | 7.43B | -9.84% | 5,346,416 | - |
| 121 | RGEN | Repligen Corporation | 7.13B | 0.53% | 935,806 | 763.34M |
| 122 | HQY | HealthEquity, Inc. | 7.10B | 0.89% | 475,214 | 1.31B |
| 123 | KYMR | Kymera Therapeutics, Inc. | 6.96B | -1.89% | 637,459 | 51.48M |
| 124 | QGEN | Qiagen N.V. | 6.93B | -2.70% | 3,134,122 | 2.10B |
| 125 | BIO | Bio-Rad Laboratories, Inc. | 6.89B | -0.66% | 268,564 | 2.59B |
| 126 | GRFS | Grifols, S.A. | 6.73B | -4.16% | 1,135,788 | 8.83B |
| 127 | BRKR | Bruker Corporation | 6.66B | 3.38% | 2,816,526 | 3.46B |
| 128 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.59B | -0.39% | 818,342 | 217.17M |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 6.36B | -4.92% | 836,845 | 74.06M |
| 130 | TGTX | TG Therapeutics, Inc. | 6.35B | 2.51% | 4,247,726 | 700.35M |
| 131 | SYRE | Spyre Therapeutics, Inc. | 6.35B | 0.14% | 923,540 | - |
| 132 | CELC | Celcuity Inc. | 6.32B | -6.26% | 1,649,276 | - |
| 133 | OSCR | Oscar Health, Inc. | 6.28B | 5.19% | 12,368,417 | 13.30B |
| 134 | MIRM | Mirum Pharmaceuticals, Inc. | 6.28B | -6.50% | 1,985,101 | 569.61M |
| 135 | BLTE | Belite Bio, Inc | 6.14B | -0.13% | 136,694 | - |
| 136 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.03% | 1,723,932 | 15.00M |
| 137 | APGE | Apogee Therapeutics, Inc. | 6.11B | -3.23% | 376,647 | - |
| 138 | CGON | CG Oncology, Inc. | 6.09B | 1.72% | 854,523 | 4.04M |
| 139 | COGT | Cogent Biosciences, Inc. | 5.95B | -3.01% | 1,997,793 | - |
| 140 | HIMS | Hims & Hers Health, Inc. | 5.93B | -4.58% | 18,601,017 | 2.35B |
| 141 | LNTH | Lantheus Holdings, Inc. | 5.91B | 5.63% | 1,666,803 | 1.55B |
| 142 | ALKS | Alkermes plc | 5.89B | 0.25% | 2,089,262 | 1.56B |
| 143 | TFX | Teleflex Incorporated | 5.83B | 6.86% | 783,892 | 2.13B |
| 144 | AVTR | Avantor, Inc. | 5.67B | -1.42% | 10,053,349 | 6.55B |
| 145 | BLCO | Bausch + Lomb Corporation | 5.67B | -0.56% | 262,686 | 5.10B |
| 146 | CHE | Chemed Corporation | 5.63B | 0.30% | 219,157 | 2.54B |
| 147 | CAI | Caris Life Sciences, Inc. | 5.61B | 3.71% | 2,313,230 | 907.29M |
| 148 | SRRK | Scholar Rock Holding Corporation | 5.54B | -1.40% | 1,888,558 | - |
| 149 | IMVT | Immunovant, Inc. | 5.54B | -5.06% | 1,238,741 | - |
| 150 | CORT | Corcept Therapeutics Incorporated | 5.48B | -2.11% | 639,187 | 769.10M |
| 151 | XENE | Xenon Pharmaceuticals Inc. | 5.41B | -4.42% | 576,359 | 7.50M |
| 152 | PTCT | PTC Therapeutics, Inc. | 5.35B | -3.12% | 1,228,127 | 1.73B |
| 153 | PACS | PACS Group, Inc. | 5.29B | -0.59% | 437,731 | 5.29B |
| 154 | LEGN | Legend Biotech Corporation | 5.28B | -1.35% | 1,357,867 | 1.03B |
| 155 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | -0.27% | 8,392,531 | 1.11B |
| 156 | CRSP | CRISPR Therapeutics AG | 5.06B | -4.83% | 1,517,644 | 4.10M |
| 157 | STVN | Stevanato Group S.p.A. | 4.92B | -5.11% | 548,342 | 1.39B |
| 158 | DOCS | Doximity, Inc. | 4.81B | 1.32% | 1,279,336 | 637.78M |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 4.67B | -5.47% | 990,143 | 1.34M |
| 160 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.55B | 4.27% | 2,061,623 | 7.70M |
| 161 | RDNT | RadNet, Inc. | 4.50B | -1.94% | 900,178 | 2.04B |
| 162 | SHC | Sotera Health Company | 4.47B | -0.82% | 3,507,041 | 1.19B |
| 163 | MANE | Veradermics, Incorporated | 4.44B | -1.75% | 592,293 | - |
| 164 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.38B | -2.23% | 545,190 | 754.05M |
| 165 | AMRX | Amneal Pharmaceuticals, Inc. | 4.38B | 0.73% | 2,009,745 | 3.05B |
| 166 | BLLN | BillionToOne, Inc. | 4.27B | 14.13% | 918,661 | 354.54M |
| 167 | HNGE | Hinge Health, Inc. | 4.26B | 0.29% | 2,753,065 | 646.34M |
| 168 | LGND | Ligand Pharmaceuticals Incorporated | 4.21B | -9.55% | 644,041 | 274.48M |
| 169 | IRTC | iRhythm Holdings, Inc. | 4.10B | 6.09% | 704,684 | 787.85M |
| 170 | WAY | Waystar Holding Corp. | 4.03B | 5.58% | 2,921,545 | 1.16B |
| 171 | NAMS | NewAmsterdam Pharma Company N.V. | 4.01B | 12.46% | 2,500,274 | 22.50M |
| 172 | TVTX | Travere Therapeutics, Inc. | 3.97B | -4.69% | 10,888,611 | 536.20M |
| 173 | NVST | Envista Holdings Corporation | 3.96B | -10.27% | 11,387,702 | 2.81B |
| 174 | LIVN | LivaNova PLC | 3.90B | 7.04% | 1,743,467 | 1.43B |
| 175 | ACAD | ACADIA Pharmaceuticals Inc. | 3.86B | 5.03% | 3,670,072 | 1.10B |
| 176 | ORKA | Oruka Therapeutics, Inc. | 3.84B | -8.20% | 1,626,598 | - |
| 177 | EWTX | Edgewise Therapeutics, Inc. | 3.83B | -3.81% | 1,169,000 | - |
| 178 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.81B | 2.11% | 13,635,489 | 588.99M |
| 179 | ALHC | Alignment Healthcare, Inc. | 3.77B | 0.61% | 2,564,151 | 4.26B |
| 180 | LQDA | Liquidia Corporation | 3.76B | 0.33% | 1,196,640 | 158.32M |
| 181 | MMSI | Merit Medical Systems, Inc. | 3.72B | 1.14% | 770,570 | 1.54B |
| 182 | TLX | Telix Pharmaceuticals Limited | 3.71B | -4.05% | 149,046 | 803.79M |
| 183 | VKTX | Viking Therapeutics, Inc. | 3.67B | -2.17% | 1,927,147 | - |
| 184 | TWST | Twist Bioscience Corporation | 3.65B | -1.66% | 1,550,659 | 409.48M |
| 185 | OGN | Organon & Co. | 3.50B | -0.67% | 8,092,063 | 6.16B |
| 186 | LFST | LifeStance Health Group, Inc. | 3.43B | 20.24% | 7,888,299 | 1.49B |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.39B | -0.59% | 2,161,924 | 62.38M |
| 188 | WRBY | Warby Parker Inc. | 3.34B | 23.47% | 8,799,891 | 890.57M |
| 189 | MMED | MiniMed Group, Inc. | 3.29B | -0.51% | 394,444 | 2.99B |
| 190 | OPCH | Option Care Health, Inc. | 3.26B | 1.47% | 5,147,542 | 5.67B |
| 191 | VCYT | Veracyte, Inc. | 3.25B | -1.04% | 1,693,004 | 541.74M |
| 192 | ERAS | Erasca, Inc. | 3.23B | -4.59% | 4,967,480 | - |
| 193 | BKD | Brookdale Senior Living Inc. | 3.22B | -4.37% | 5,330,489 | 3.00B |
| 194 | BEAM | Beam Therapeutics Inc. | 3.15B | -2.69% | 1,755,313 | 164.01M |
| 195 | DNLI | Denali Therapeutics Inc. | 3.13B | -3.43% | 684,096 | - |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.12B | -4.69% | 893,070 | 236.00M |
| 197 | ICUI | ICU Medical, Inc. | 3.08B | 2.91% | 326,726 | 2.23B |
| 198 | SUPN | Supernus Pharmaceuticals, Inc. | 3.03B | 1.61% | 1,055,334 | 776.83M |
| 199 | CON | Concentra Group Holdings Parent, Inc. | 3.03B | 3.42% | 1,658,333 | 2.16B |
| 200 | ALMS | Alumis Inc. | 3.02B | -6.82% | 923,819 | 24.05M |
| 201 | PRVA | Privia Health Group, Inc. | 3.01B | - | 2,868,795 | 2.25B |
| 202 | ITGR | Integer Holdings Corporation | 2.99B | 1.89% | 330,246 | 1.86B |
| 203 | KLRA | Kailera Therapeutics, Inc. | 2.91B | -9.03% | 280,014 | - |
| 204 | DYN | Dyne Therapeutics, Inc. | 2.90B | -6.90% | 1,691,227 | - |
| 205 | TXG | 10x Genomics, Inc. | 2.89B | -1.41% | 2,278,862 | 642.82M |
| 206 | NKTR | Nektar Therapeutics | 2.81B | -2.02% | 450,527 | 55.23M |
| 207 | GPCR | Structure Therapeutics Inc. | 2.78B | -4.14% | 738,641 | - |
| 208 | TARS | Tarsus Pharmaceuticals, Inc. | 2.75B | -1.24% | 1,567,842 | 535.08M |
| 209 | SLNO | Soleno Therapeutics, Inc. | 2.74B | 0.02% | 1,982,269 | 190.41M |
| 210 | KOD | Kodiak Sciences Inc. | 2.71B | -4.82% | 367,619 | - |
| 211 | GRAL | GRAIL, Inc. | 2.70B | 0.27% | 643,168 | 156.12M |
| 212 | NHC | National HealthCare Corporation | 2.67B | 1.19% | 26,135 | 1.52B |
| 213 | CLDX | Celldex Therapeutics, Inc. | 2.61B | -3.11% | 886,619 | 1.55M |
| 214 | HTFL | HeartFlow, Inc. | 2.59B | -1.02% | 526,267 | 176.03M |
| 215 | ARQT | Arcutis Biotherapeutics, Inc. | 2.58B | -14.52% | 6,822,559 | 415.62M |
| 216 | PBH | Prestige Consumer Healthcare Inc. | 2.58B | 0.52% | 700,240 | 1.10B |
| 217 | IRON | Disc Medicine, Inc. | 2.58B | -1.63% | 395,188 | - |
| 218 | VERA | Vera Therapeutics, Inc. | 2.57B | -1.95% | 972,542 | - |
| 219 | RARE | Ultragenyx Pharmaceutical Inc. | 2.57B | 0.77% | 1,124,958 | 670.00M |
| 220 | DFTX | Definium Therapeutics, Inc. | 2.53B | -0.94% | 1,752,464 | - |
| 221 | HAE | Haemonetics Corporation | 2.53B | 3.23% | 1,614,924 | 1.33B |
| 222 | TMDX | TransMedics Group, Inc. | 2.52B | -0.03% | 1,485,955 | 635.89M |
| 223 | IMNM | Immunome, Inc. | 2.51B | -4.64% | 609,102 | 6.94M |
| 224 | IDYA | IDEAYA Biosciences, Inc. | 2.48B | -1.74% | 947,750 | 225.27M |
| 225 | LMAT | LeMaitre Vascular, Inc. | 2.47B | -2.10% | 363,632 | 256.28M |
| 226 | ELVN | Enliven Therapeutics, Inc. | 2.45B | -2.21% | 461,010 | - |
| 227 | MLYS | Mineralys Therapeutics, Inc. | 2.42B | -2.56% | 1,701,982 | - |
| 228 | RLAY | Relay Therapeutics, Inc. | 2.40B | -3.17% | 2,886,089 | 10.68M |
| 229 | ADPT | Adaptive Biotechnologies Corporation | 2.35B | 1.80% | 1,950,094 | 295.41M |
| 230 | AXGN | Axogen, Inc. | 2.31B | -0.16% | 880,539 | 238.11M |
| 231 | GRDN | Guardian Pharmacy Services, Inc. | 2.30B | -0.85% | 1,107,026 | 1.46B |
| 232 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.26B | 0.79% | 5,549,179 | 885.72M |
| 233 | HCM | HUTCHMED (China) Limited | 2.26B | -0.89% | 16,244 | 548.51M |
| 234 | ACHC | Acadia Healthcare Company, Inc. | 2.25B | -3.32% | 2,268,148 | 3.37B |
| 235 | ZLAB | Zai Lab Limited | 2.22B | -5.93% | 859,841 | 460.16M |
| 236 | SRPT | Sarepta Therapeutics, Inc. | 2.20B | -9.68% | 2,394,137 | 2.18B |
| 237 | XRAY | DENTSPLY SIRONA Inc. | 2.20B | -1.62% | 6,611,721 | 3.68B |
| 238 | BHC | Bausch Health Companies Inc. | 2.14B | 1.42% | 1,883,470 | 10.53B |
| 239 | OCUL | Ocular Therapeutix, Inc. | 2.12B | -0.31% | 2,104,417 | 52.04M |
| 240 | ESTA | Establishment Labs Holdings Inc. | 2.12B | -3.37% | 552,827 | 229.58M |
| 241 | AAPG | Ascentage Pharma Group International | 2.06B | 0.60% | 1,984 | 82.08M |
| 242 | NBTX | Nanobiotix S.A. | 2.05B | 2.08% | 119,331 | 38.27M |
| 243 | STOK | Stoke Therapeutics, Inc. | 2.04B | -1.47% | 407,327 | 184.42M |
| 244 | SEM | Select Medical Holdings Corporation | 2.04B | 0.06% | 1,583,914 | 5.52B |
| 245 | NEOG | Neogen Corporation | 2.01B | 0.76% | 1,635,635 | 870.56M |
| 246 | TRVI | Trevi Therapeutics, Inc. | 1.99B | -1.47% | 2,118,862 | - |
| 247 | OMCL | Omnicell, Inc. | 1.97B | -0.98% | 384,728 | 1.23B |
| 248 | ADMA | ADMA Biologics, Inc. | 1.97B | -15.97% | 29,720,937 | 509.86M |
| 249 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | -6.80% | 2,661,052 | 298.30M |
| 250 | CAPR | Capricor Therapeutics, Inc. | 1.96B | -1.28% | 752,996 | 11.13M |
| 251 | MESO | Mesoblast Limited | 1.96B | -6.39% | 201,735 | 65.38M |
| 252 | ZYME | Zymeworks Inc. | 1.96B | -3.66% | 707,858 | 105.97M |
| 253 | TYRA | Tyra Biosciences, Inc. | 1.96B | -2.66% | 565,808 | - |
| 254 | SION | Sionna Therapeutics, Inc. | 1.96B | 0.05% | 777,420 | - |
| 255 | NVCR | NovoCure Limited | 1.95B | 2.03% | 1,233,715 | 674.41M |
| 256 | PHVS | Pharvaris N.V. | 1.94B | -1.73% | 213,772 | - |
| 257 | ANAB | AnaptysBio, Inc. | 1.92B | -0.59% | 1,390,621 | 234.60M |
| 258 | TSHA | Taysha Gene Therapies, Inc. | 1.92B | -4.44% | 2,782,374 | 7.47M |
| 259 | NTLA | Intellia Therapeutics, Inc. | 1.92B | -1.01% | 3,533,471 | 67.67M |
| 260 | ANIP | ANI Pharmaceuticals, Inc. | 1.91B | -0.18% | 399,921 | 883.37M |
| 261 | RAPP | Rapport Therapeutics, Inc. | 1.91B | 7.74% | 997,412 | 20.00M |
| 262 | SGRY | Surgery Partners, Inc. | 1.85B | -1.92% | 1,452,392 | 3.34B |
| 263 | OCS | Oculis Holding AG | 1.84B | 5.10% | 582,754 | 1.51M |
| 264 | MD | Pediatrix Medical Group, Inc. | 1.84B | 3.24% | 968,381 | 1.93B |
| 265 | GLPG | Galapagos NV | 1.83B | -3.75% | 288,095 | 1.20B |
| 266 | SNDX | Syndax Pharmaceuticals, Inc. | 1.82B | -0.53% | 1,187,909 | 217.17M |
| 267 | INBX | Inhibrx Biosciences, Inc. | 1.82B | -12.21% | 441,931 | 1.30M |
| 268 | HRMY | Harmony Biosciences Holdings, Inc. | 1.82B | -4.15% | 2,229,891 | 899.11M |
| 269 | VCEL | Vericel Corporation | 1.79B | -4.49% | 1,192,575 | 292.09M |
| 270 | ASTH | Astrana Health, Inc. | 1.78B | 2.35% | 614,200 | 3.53B |
| 271 | ADUS | Addus HomeCare Corporation | 1.78B | 0.67% | 318,418 | 1.45B |
| 272 | VRDN | Viridian Therapeutics, Inc. | 1.75B | -3.02% | 11,273,088 | 70.92M |
| 273 | PAHC | Phibro Animal Health Corporation | 1.75B | -26.22% | 1,572,778 | 1.50B |
| 274 | GENB | Generate Biomedicines, Inc. | 1.73B | -11.21% | 318,023 | 31.89M |
| 275 | RXRX | Recursion Pharmaceuticals, Inc. | 1.73B | -4.66% | 12,032,114 | 66.41M |
| 276 | ARDX | Ardelyx, Inc. | 1.72B | -1.69% | 3,921,218 | 427.68M |
| 277 | AHG | Akso Health Group | 1.72B | -1.95% | 202,280 | 14.84M |
| 278 | AORT | Artivion, Inc. | 1.72B | 1.99% | 898,541 | 441.33M |
| 279 | UFPT | UFP Technologies, Inc. | 1.71B | 1.44% | 267,206 | 608.85M |
| 280 | SNDA | Sonida Senior Living, Inc. | 1.71B | -1.62% | 653,169 | 336.39M |
| 281 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.69B | -5.35% | 1,451,468 | -665.00K |
| 282 | INVA | Innoviva, Inc. | 1.68B | 0.98% | 1,126,740 | 420.69M |
| 283 | NRIX | Nurix Therapeutics, Inc. | 1.68B | -3.55% | 491,423 | 71.78M |
| 284 | NUVB | Nuvation Bio Inc. | 1.67B | -4.56% | 4,107,904 | 143.05M |
| 285 | MBX | MBX Biosciences, Inc. | 1.65B | 8.06% | 928,267 | - |
| 286 | AGIO | Agios Pharmaceuticals, Inc. | 1.64B | 2.04% | 722,493 | 66.05M |
| 287 | PVLA | Palvella Therapeutics, Inc. | 1.62B | -12.99% | 571,436 | - |
| 288 | ALMR | Alamar Biosciences, Inc. | 1.61B | -0.76% | 270,070 | 74.21M |
| 289 | PRGO | Perrigo Company plc | 1.61B | -4.40% | 2,698,816 | 4.18B |
| 290 | GLUE | Monte Rosa Therapeutics, Inc. | 1.59B | -2.84% | 661,133 | 42.95M |
| 291 | ENOV | Enovis Corporation | 1.57B | 9.66% | 1,940,813 | 2.28B |
| 292 | AHCO | AdaptHealth Corp. | 1.56B | 2.71% | 1,953,016 | 3.29B |
| 293 | IMCR | Immunocore Holdings plc | 1.56B | -0.36% | 358,192 | 412.81M |
| 294 | HCSG | Healthcare Services Group, Inc. | 1.53B | 1.04% | 744,479 | 1.85B |
| 295 | QURE | uniQure N.V. | 1.52B | 5.83% | 1,789,199 | 18.09M |
| 296 | NVAX | Novavax, Inc. | 1.52B | -1.39% | 3,928,242 | 596.34M |
| 297 | BCAX | Bicara Therapeutics Inc. | 1.51B | -2.90% | 345,249 | - |
| 298 | AVAH | Aveanna Healthcare Holdings Inc. | 1.51B | 2.66% | 1,480,659 | 2.43B |
| 299 | DMRA | Damora Therapeutics, Inc. | 1.51B | 1.22% | 1,874,369 | - |
| 300 | PGNY | Progyny, Inc. | 1.50B | 2.46% | 1,260,788 | 1.29B |
| 301 | VIR | Vir Biotechnology, Inc. | 1.49B | -9.91% | 2,787,903 | 65.50M |
| 302 | IMTX | Immatics N.V. | 1.49B | -3.21% | 735,713 | 56.67M |
| 303 | CLOV | Clover Health Investments, Corp. | 1.48B | 5.22% | 8,318,369 | 2.21B |
| 304 | FTRE | Fortrea Holdings Inc. | 1.47B | -0.45% | 1,631,239 | 2.71B |
| 305 | ATAI | AtaiBeckley Inc. | 1.47B | -3.84% | 4,337,939 | 4.09M |
| 306 | PGEN | Precigen, Inc. | 1.47B | -5.68% | 3,096,739 | 9.68M |
| 307 | BHVN | Biohaven Ltd. | 1.47B | -2.99% | 628,207 | - |
| 308 | IOVA | Iovance Biotherapeutics, Inc. | 1.46B | -13.20% | 40,917,558 | 285.61M |
| 309 | ABCL | AbCellera Biologics Inc. | 1.46B | -4.37% | 11,261,567 | 75.13M |
| 310 | HROW | Harrow, Inc. | 1.46B | -3.03% | 431,308 | 272.30M |
| 311 | PRCT | PROCEPT BioRobotics Corporation | 1.45B | 2.58% | 1,040,232 | 322.02M |
| 312 | ARDT | Ardent Health, Inc. | 1.42B | 5.66% | 656,876 | 6.43B |
| 313 | MAZE | Maze Therapeutics, Inc. | 1.41B | -3.78% | 468,614 | 2.50M |
| 314 | ATRC | AtriCure, Inc. | 1.41B | -0.75% | 1,005,631 | 552.16M |
| 315 | WVE | Wave Life Sciences Ltd. | 1.39B | -0.69% | 4,241,613 | 71.80M |
| 316 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | - | 1,504,167 | 73.62M |
| 317 | STAA | STAAR Surgical Company | 1.35B | -1.69% | 650,682 | 239.44M |
| 318 | AVBP | ArriVent BioPharma, Inc. | 1.34B | -2.60% | 342,962 | - |
| 319 | PLSE | Pulse Biosciences, Inc. | 1.34B | 1.98% | 222,168 | 751.00K |
| 320 | MPLT | MapLight Therapeutics, Inc. | 1.32B | 0.55% | 210,434 | - |
| 321 | OLMA | Olema Pharmaceuticals, Inc. | 1.32B | -0.39% | 1,222,924 | - |
| 322 | INSP | Inspire Medical Systems, Inc. | 1.31B | -0.28% | 2,005,804 | 915.25M |
| 323 | SVRA | Savara Inc. | 1.31B | -2.09% | 727,792 | - |
| 324 | GHRS | GH Research PLC | 1.30B | -6.37% | 198,490 | - |
| 325 | URGN | UroGen Pharma Ltd. | 1.30B | 1.30% | 1,338,194 | 140.49M |
| 326 | COLL | Collegium Pharmaceutical, Inc. | 1.27B | 7.72% | 913,790 | 796.33M |
| 327 | CMPS | COMPASS Pathways plc | 1.27B | -3.79% | 2,807,270 | - |
| 328 | TNDM | Tandem Diabetes Care, Inc. | 1.27B | 2.44% | 2,297,239 | 1.01B |
| 329 | TDOC | Teladoc Health, Inc. | 1.26B | 2.35% | 7,459,738 | 2.51B |
| 330 | KMTS | Kestra Medical Technologies, Ltd. | 1.26B | 3.91% | 233,778 | 83.72M |
| 331 | PNTG | The Pennant Group, Inc. | 1.25B | 9.84% | 563,913 | 1.02B |
| 332 | MLTX | MoonLake Immunotherapeutics | 1.23B | -2.82% | 765,267 | - |
| 333 | CRVS | Corvus Pharmaceuticals, Inc. | 1.23B | -5.57% | 1,350,352 | - |
| 334 | WGS | GeneDx Holdings Corp. | 1.20B | 16.68% | 4,232,589 | 442.68M |
| 335 | JBIO | Jade Biosciences, Inc. | 1.20B | -3.62% | 380,696 | - |
| 336 | ATEC | Alphatec Holdings, Inc. | 1.19B | 10.87% | 11,375,119 | 787.08M |
| 337 | NEO | NeoGenomics, Inc. | 1.18B | 2.02% | 804,677 | 745.97M |
| 338 | DBVT | DBV Technologies S.A. | 1.17B | -0.60% | 108,082 | 5.74M |
| 339 | AVNS | Avanos Medical, Inc. | 1.16B | 0.20% | 1,514,660 | 715.90M |
| 340 | CNMD | CONMED Corporation | 1.15B | 2.09% | 378,334 | 1.37B |
| 341 | ZBIO | Zenas BioPharma, Inc. | 1.15B | -7.49% | 448,451 | 10.00M |
| 342 | XERS | Xeris Biopharma Holdings, Inc. | 1.14B | 4.08% | 5,566,548 | 314.85M |
| 343 | COAG | Hemab Therapeutics Holdings, Inc. | 1.14B | 2.92% | 202,109 | - |
| 344 | NNNN | Anbio Biotechnology | 1.14B | -2.71% | 16,321 | 8.65M |
| 345 | AVLN | Avalyn Pharma Inc. | 1.13B | -2.81% | 664,375 | - |
| 346 | EYPT | EyePoint, Inc. | 1.12B | 0.45% | 1,122,334 | 7.61M |
| 347 | BLFS | BioLife Solutions, Inc. | 1.12B | 6.30% | 530,260 | 96.21M |
| 348 | EVO | Evotec SE | 1.11B | -5.86% | 98,251 | 925.65M |
| 349 | BFLY | Butterfly Network, Inc. | 1.11B | -6.81% | 3,624,220 | 102.92M |
| 350 | IRMD | IRADIMED CORPORATION | 1.11B | 0.58% | 77,342 | 86.28M |
| 351 | CDNA | CareDx, Inc. | 1.11B | 2.34% | 647,171 | 412.82M |
| 352 | IVA | Inventiva S.A. | 1.10B | -0.74% | 374,110 | 7.94M |
| 353 | INNV | InnovAge Holding Corp. | 1.10B | -0.49% | 259,451 | 949.17M |
| 354 | MNKD | MannKind Corporation | 1.10B | -0.28% | 7,653,088 | 360.78M |
| 355 | SEPN | Septerna, Inc. | 1.08B | -2.95% | 218,326 | 45.95M |
| 356 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.07B | 0.54% | 373,431 | 719.89M |
| 357 | IART | Integra LifeSciences Holdings Corporation | 1.06B | -2.82% | 1,769,486 | 1.64B |
| 358 | OMER | Omeros Corporation | 1.05B | -1.28% | 737,426 | - |
| 359 | AKTS | Aktis Oncology, Inc. | 1.04B | -5.92% | 171,505 | 6.50M |
| 360 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.02B | - | 3,162,880 | 185.74M |
| 361 | AGL | agilon health, inc. | 1.01B | 117.81% | 1,575,335 | 5.82B |
| 362 | ALVO | Alvotech | 1.00B | -10.36% | 716,399 | 562.04M |
| 363 | CRON | Cronos Group Inc. | 994.40M | -1.91% | 1,291,129 | 146.59M |
| 364 | SDGR | Schrödinger, Inc. | 992.29M | 2.31% | 1,235,050 | 254.91M |
| 365 | LMRI | Lumexa Imaging Holdings, Inc. | 984.17M | -0.39% | 295,066 | 1.02B |
| 366 | OMDA | Omada Health, Inc. | 974.41M | 3.40% | 2,112,352 | 260.21M |
| 367 | GDRX | GoodRx Holdings, Inc. | 972.91M | 10.51% | 4,512,275 | 787.89M |
| 368 | PHAT | Phathom Pharmaceuticals, Inc. | 971.43M | -3.47% | 808,490 | 204.89M |
| 369 | SANA | Sana Biotechnology, Inc. | 971.25M | -3.85% | 2,137,178 | - |
| 370 | CERT | Certara, Inc. | 967.48M | 0.80% | 2,000,368 | 418.84M |
| 371 | GERN | Geron Corporation | 935.71M | -7.59% | 17,372,057 | 196.12M |
| 372 | PCRX | Pacira BioSciences, Inc. | 930.18M | -0.21% | 567,820 | 734.86M |
| 373 | NUTX | Nutex Health Inc. | 926.16M | 3.06% | 109,722 | 879.95M |
| 374 | LBRX | LB Pharmaceuticals Inc | 917.05M | -0.06% | 85,753 | - |
| 375 | XNCR | Xencor, Inc. | 912.51M | -5.38% | 947,693 | 97.36M |
| 376 | ORIC | ORIC Pharmaceuticals, Inc. | 911.99M | -5.27% | 1,343,811 | - |
| 377 | SLS | SELLAS Life Sciences Group, Inc. | 909.75M | -4.27% | 2,221,970 | - |
| 378 | CGEM | Cullinan Therapeutics, Inc. | 904.56M | -1.80% | 1,227,571 | - |
| 379 | USPH | U.S. Physical Therapy, Inc. | 898.59M | -19.89% | 476,919 | 787.69M |
| 380 | ANNX | Annexon, Inc. | 897.04M | -3.16% | 2,357,564 | - |
| 381 | MGTX | MeiraGTx Holdings plc | 895.03M | -2.32% | 435,679 | 81.39M |
| 382 | ABSI | Absci Corporation | 893.82M | -3.36% | 6,556,083 | 2.80M |
| 383 | SPRY | ARS Pharmaceuticals, Inc. | 893.68M | -3.02% | 1,479,809 | 84.28M |
| 384 | BVS | Bioventus Inc. | 889.65M | -2.47% | 887,110 | 576.30M |
| 385 | JANX | Janux Therapeutics, Inc. | 886.38M | -0.55% | 622,935 | 10.00M |
| 386 | INMD | InMode Ltd. | 881.95M | 2.43% | 1,447,716 | 374.64M |
| 387 | DSGN | Design Therapeutics, Inc. | 880.64M | -3.09% | 394,077 | - |
| 388 | TBPH | Theravance Biopharma, Inc. | 876.78M | 0.47% | 346,753 | 109.78M |
| 389 | DRUG | Bright Minds Biosciences Inc. | 874.60M | -0.10% | 140,145 | - |
| 390 | VOR | Vor Biopharma Inc. | 871.31M | 1.13% | 750,220 | - |
| 391 | CTMX | CytomX Therapeutics, Inc. | 870.78M | -3.15% | 3,097,083 | 76.20M |
| 392 | AMN | AMN Healthcare Services, Inc. | 867.83M | 7.06% | 1,755,338 | 3.42B |
| 393 | TALK | Talkspace, Inc. | 865.45M | -0.19% | 1,590,314 | 228.87M |
| 394 | PHAR | Pharming Group N.V. | 860.79M | -26.83% | 96,019 | 369.49M |
| 395 | ABUS | Arbutus Biopharma Corporation | 856.69M | -1.58% | 923,760 | 14.08M |
| 396 | AZTA | Azenta, Inc. | 855.92M | 1.03% | 2,258,001 | 596.48M |
| 397 | ETON | Eton Pharmaceuticals, Inc. | 848.70M | 2.89% | 607,157 | 79.95M |
| 398 | SGP | SpyGlass Pharma, Inc. | 847.53M | 1.20% | 134,541 | - |
| 399 | OPK | OPKO Health, Inc. | 845.70M | - | 1,712,371 | 581.12M |
| 400 | ANRO | Alto Neuroscience, Inc. | 843.72M | -1.71% | 581,296 | - |
| 401 | KURA | Kura Oncology, Inc. | 827.27M | -2.51% | 947,606 | 67.48M |
| 402 | SPTX | Seaport Therapeutics, Inc. | 821.93M | -3.13% | 429,745 | - |
| 403 | EVMN | Evommune, Inc. | 810.41M | -5.58% | 289,419 | 13.00M |
| 404 | ESPR | Esperion Therapeutics, Inc. | 808.25M | -0.32% | 18,275,608 | 403.14M |
| 405 | BIOA | BioAge Labs, Inc. | 791.17M | -3.47% | 223,666 | 9.00M |
| 406 | SSII | SS Innovations International, Inc. | 785.76M | -3.44% | 29,801 | 42.48M |
| 407 | ALLO | Allogene Therapeutics, Inc. | 780.83M | -1.73% | 3,275,481 | 22.00K |
| 408 | RLMD | Relmada Therapeutics, Inc. | 779.32M | -5.47% | 679,817 | - |
| 409 | CBLL | CeriBell, Inc. | 774.11M | 1.44% | 239,214 | 89.06M |
| 410 | QDEL | QuidelOrtho Corporation | 734.42M | -1.73% | 2,792,209 | 2.66B |
| 411 | LXRX | Lexicon Pharmaceuticals, Inc. | 711.78M | 5.00% | 4,945,066 | 49.80M |
| 412 | EHAB | Enhabit, Inc. | 698.46M | - | 497,916 | 1.06B |
| 413 | SLDB | Solid Biosciences Inc. | 695.78M | -1.81% | 752,668 | - |
| 414 | DRTS | Alpha Tau Medical Ltd. | 690.88M | 3.43% | 509,778 | - |
| 415 | HSTM | HealthStream, Inc. | 689.85M | 1.68% | 347,714 | 311.78M |
| 416 | IRWD | Ironwood Pharmaceuticals, Inc. | 686.44M | -13.66% | 4,964,195 | 361.51M |
| 417 | BWAY | BrainsWay Ltd. | 686.37M | 1.83% | 102,529 | 52.23M |
| 418 | TENX | Tenax Therapeutics, Inc. | 685.93M | -3.08% | 888,565 | - |
| 419 | GYRE | Gyre Therapeutics, Inc. | 685.75M | -12.06% | 96,958 | 117.05M |
| 420 | ACRS | Aclaris Therapeutics, Inc. | 678.77M | 1.67% | 1,135,662 | 8.37M |
| 421 | TLRY | Tilray Brands, Inc. | 675.14M | -1.74% | 4,017,441 | 858.28M |
| 422 | STRO | Sutro Biopharma, Inc. | 659.90M | 5.68% | 258,046 | 102.48M |
| 423 | NPCE | NeuroPace, Inc. | 654.90M | 6.46% | 369,580 | 99.99M |
| 424 | CABA | Cabaletta Bio, Inc. | 652.20M | 7.24% | 4,731,242 | - |
| 425 | ARVN | Arvinas, Inc. | 651.76M | -0.68% | 784,308 | 262.60M |
| 426 | ZVRA | Zevra Therapeutics, Inc. | 650.26M | -2.22% | 2,618,028 | 122.29M |
| 427 | FBRX | Forte Biosciences, Inc. | 640.59M | -1.32% | 120,662 | - |
| 428 | CTKB | Cytek Biosciences, Inc. | 635.38M | -0.40% | 780,836 | 201.49M |
| 429 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 629.06M | -5.64% | 374,544 | - |
| 430 | PSNL | Personalis, Inc. | 627.02M | -1.32% | 1,510,199 | 69.65M |
| 431 | CRMD | CorMedix Inc. | 621.15M | -1.61% | 767,802 | 311.71M |
| 432 | TRAX | First Tracks Biotherapeutics, Inc. | 619.22M | -12.00% | 542,671 | - |
| 433 | AVTX | Avalo Therapeutics, Inc. | 610.96M | 4.86% | 5,741,760 | 59.00K |
| 434 | DNA | Ginkgo Bioworks Holdings, Inc. | 600.70M | 2.38% | 1,856,333 | 170.16M |
| 435 | CBIO | Crescent Biopharma, Inc. | 598.12M | -0.33% | 77,647 | 11.88M |
| 436 | PHR | Phreesia, Inc. | 597.30M | 3.15% | 1,148,444 | 480.59M |
| 437 | ALT | Altimmune, Inc. | 590.37M | -6.75% | 1,907,072 | 41.00K |
| 438 | TCMD | Tactile Systems Technology, Inc. | 586.69M | 2.81% | 597,290 | 343.52M |
| 439 | CSTL | Castle Biosciences, Inc. | 582.89M | -22.26% | 1,999,179 | 339.92M |
| 440 | AVR | Anteris Technologies Global Corp. | 576.42M | 1.88% | 490,673 | 1.91M |
| 441 | SIBN | SI-BONE, Inc. | 572.96M | -0.31% | 453,416 | 200.93M |
| 442 | CADL | Candel Therapeutics, Inc. | 570.59M | 2.10% | 2,241,982 | - |
| 443 | CLYM | Climb Bio, Inc. | 568.92M | -2.54% | 929,950 | - |
| 444 | PROK | ProKidney Corp. | 567.69M | -4.08% | 847,390 | 893.00K |
| 445 | PRTA | Prothena Corporation plc | 566.32M | -5.90% | 443,068 | 9.68M |
| 446 | KYTX | Kyverna Therapeutics, Inc. | 562.93M | -1.80% | 431,084 | - |
| 447 | AGMB | AgomAb Therapeutics NV | 562.41M | -6.70% | 71,147 | - |
| 448 | PRME | Prime Medicine, Inc. | 551.80M | -8.65% | 3,957,705 | 4.03M |
| 449 | MDXG | MiMedx Group, Inc. | 549.61M | 0.82% | 1,529,570 | 389.42M |
| 450 | ANL | Adlai Nortye Ltd. | 548.00M | -3.99% | 183,506 | 5.00M |
| 451 | VALN | Valneva SE | 546.89M | 4.07% | 37,974 | 205.07M |
| 452 | CTNM | Contineum Therapeutics, Inc. | 546.23M | -2.07% | 171,484 | - |
| 453 | RGNX | REGENXBIO Inc. | 537.85M | 1.96% | 1,317,696 | 170.44M |
| 454 | AURA | Aura Biosciences, Inc. | 526.44M | -1.09% | 404,746 | - |
| 455 | AQST | Aquestive Therapeutics, Inc. | 525.72M | - | 1,307,296 | 44.55M |
| 456 | CERS | Cerus Corporation | 522.96M | 0.77% | 2,196,380 | 216.56M |
| 457 | FDMT | 4D Molecular Therapeutics, Inc. | 519.09M | -4.70% | 737,281 | 85.21M |
| 458 | PRLD | Prelude Therapeutics Incorporated | 517.85M | 6.40% | 546,593 | 12.14M |
| 459 | PACB | Pacific Biosciences of California, Inc. | 512.30M | -3.51% | 6,280,151 | 160.01M |
| 460 | TECX | Tectonic Therapeutic, Inc. | 506.46M | -7.41% | 242,009 | - |
| 461 | IMMX | Immix Biopharma, Inc. | 505.74M | -7.56% | 649,083 | - |
| 462 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 463 | VSTM | Verastem, Inc. | 497.19M | -5.82% | 2,890,146 | 30.91M |
| 464 | EIKN | Eikon Therapeutics, Inc. | 496.45M | -8.02% | 238,783 | - |
| 465 | VREX | Varex Imaging Corporation | 495.91M | -2.79% | 563,451 | 854.40M |
| 466 | XOMA | XOMA Royalty Corporation | 492.00M | -0.75% | 194,875 | 52.15M |
| 467 | ASMB | Assembly Biosciences, Inc. | 491.56M | -1.37% | 163,651 | 72.30M |
| 468 | UPB | Upstream Bio, Inc. | 488.96M | -2.23% | 272,835 | 2.85M |
| 469 | NGNE | Neurogene Inc. | 488.15M | -3.31% | 152,687 | 925.00K |
| 470 | KMDA | Kamada Ltd. | 487.92M | 0.36% | 60,476 | 180.46M |
| 471 | OFIX | Orthofix Medical Inc. | 487.89M | -0.98% | 344,506 | 825.37M |
| 472 | OCGN | Ocugen, Inc. | 487.46M | -1.03% | 5,151,941 | 4.47M |
| 473 | EVH | Evolent Health, Inc. | 486.86M | 11.49% | 5,981,732 | 1.89B |
| 474 | RIGL | Rigel Pharmaceuticals, Inc. | 485.49M | -1.61% | 210,297 | 299.77M |
| 475 | WEAV | Weave Communications, Inc. | 481.37M | 0.67% | 1,408,201 | 248.72M |
| 476 | ADCT | ADC Therapeutics SA | 476.97M | -2.85% | 671,594 | 79.18M |
| 477 | STTK | Shattuck Labs, Inc. | 473.14M | -6.29% | 695,663 | 1.00M |
| 478 | OVID | Ovid Therapeutics Inc. | 472.39M | -1.80% | 1,379,641 | 7.25M |
| 479 | SGMT | Sagimet Biosciences Inc. | 471.78M | -8.83% | 1,034,260 | - |
| 480 | EBS | Emergent BioSolutions Inc. | 471.07M | 0.33% | 298,451 | 676.80M |
| 481 | ANGO | AngioDynamics, Inc. | 469.76M | 1.99% | 228,360 | 313.73M |
| 482 | LYEL | Lyell Immunopharma, Inc. | 468.05M | -3.79% | 52,199 | 31.00K |
| 483 | BBNX | Beta Bionics, Inc. | 467.90M | -0.66% | 459,449 | 110.24M |
| 484 | EPRX | Eupraxia Pharmaceuticals Inc. | 462.22M | -1.45% | 127,097 | - |
| 485 | SRTA | Strata Critical Medical, Inc. | 462.03M | 0.19% | 1,352,697 | 228.58M |
| 486 | FULC | Fulcrum Therapeutics, Inc. | 458.44M | -3.23% | 459,330 | 80.00M |
| 487 | KIDS | OrthoPediatrics Corp. | 451.29M | 2.63% | 200,504 | 243.30M |
| 488 | AVIR | Atea Pharmaceuticals, Inc. | 443.35M | -1.95% | 192,201 | - |
| 489 | ENTA | Enanta Pharmaceuticals, Inc. | 437.90M | -0.98% | 196,473 | 66.98M |
| 490 | CGC | Canopy Growth Corporation | 432.79M | -1.74% | 3,429,090 | 203.04M |
| 491 | LXEO | Lexeo Therapeutics, Inc. | 431.19M | -6.58% | 571,920 | - |
| 492 | ZURA | Zura Bio Limited | 430.76M | -7.16% | 976,626 | - |
| 493 | FLGT | Fulgent Genetics, Inc. | 429.13M | 1.27% | 591,955 | 320.35M |
| 494 | AUTL | Autolus Therapeutics plc | 428.49M | -5.29% | 1,205,707 | 75.39M |
| 495 | PRTC | PureTech Health plc | 424.14M | -0.21% | 39,997 | 4.66M |
| 496 | NRC | NRC Health | 422.11M | 4.87% | 207,073 | 138.64M |
| 497 | CCRN | Cross Country Healthcare, Inc. | 421.49M | 29.48% | 5,561,230 | 1.05B |
| 498 | EOLS | Evolus, Inc. | 420.81M | 1.11% | 938,433 | 301.79M |
| 499 | MNPR | Monopar Therapeutics Inc. | 417.79M | -2.24% | 198,348 | - |
| 500 | IPSC | Century Therapeutics, Inc. | 416.62M | -1.28% | 729,945 | 109.16M |